Product
QLS31904
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
An Open-label, Phase 1 Study of QLS31904 as Monotherapy to Assess the Safety, Tolerability and PK in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-09-25